New scientists (916 résultats)

Etat : acceptable. This copy has clearly been enjoyedâ"expect noticeable shelf wear and some minor creases to the cover. Binding is strong, and all pages are legible. May contain previous library markings or stamps.

paperback. Etat : Very Good.

Paperback. Etat : Very Good. Drug development, the processes by which a chemical compound becomes a drug and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you're involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound's development. If you're a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products.…

Paperback. Etat : Good. Drug development, the processes by which a chemical compound becomes a drug and is approved for sale by the FDA and European and Asian regulators, is not for the faint-of-heart or the shortsighted. Designing and monitoring studies, obtaining and analyzing scientific data, and reconciling clinical results against the ethical constraints and regulatory guidelines of government agencies, requires a complex interaction of in-house specialists and academic and commercial consultants worldwide. Scientific, technical, and tactical considerations play out in an environment where a balance must be struck between the often-competing interests of the corporation, its investors, government regulators, and the safety and well being of intended patients. All the while, dwindling patent protections impose an ever-contracting timeframe for success. Written to be accessible to a wide audience, NEW DRUGS provides a thorough, succinct, and practical understanding of these drug-development processes. If you're involved in the pharmaceutical industry, NEW DRUGS will provide scientific and management tools to increase the likelihood of regulatory approval at each phase of your compound's development. If you're a patient or consumer, NEW DRUGS will enable you to intelligently discuss medications with your health-care provider and empower you to make informed decisions at the pharmacy. If your portfolio, rather than your health, makes you an interested observer of the fortunes of this critical sector of the US economy, NEW DRUGS will help you to decode press releases and annual reports, so that you can recognize and invest in well-run companies with promising products.…

Etat : very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service.

paperback. Etat : As New. Bishop, Nic (illustrateur).

paperback. Etat : Very Good. Bishop, Nic (illustrateur).

Paperback. Etat : Very Good.

Etat : very_good. This book is in excellent condition. There may be minimal writing on the inside cover or cover page. Cover image on the book may vary from photo. Ships out quickly in a secure plastic mailer.

Etat : very_good. Fast Free Shipping â" Very Good condition book with a firm cover and clean pages. Shows normal use and some light wear or limited notes markings. A solid, nice copy to enjoy.

Etat : good. Fast Free Shipping â" Good condition. It may show normal signs of use, such as light writing, highlighting, or library markings, but all pages are intact and the book is fully readable. A solid, complete copy that's ready to enjoy.

Etat : Good. . . All orders guaranteed and ship within 24 hours. Before placing your order for please contact us for confirmation on the book's binding. Check out our other listings to add to your order for discounted shipping.

Paperback. Etat : Fair. Many young Christians interested in the sciences have felt torn between two options: remaining faithful to Christ or studying science. Heated debates over the past century have created the impression that we have to choose between one or the other. The result has been a crisis of faith for many students. Josh Reeves and Steve Donaldson present a concise introduction to the study of science that explains why scientists in every age have found science congenial to their faith and how Christians in the sciences can bridge the gap between science and Christian belief and practice. If Christians are to have a beneficial dialogue with science, it will be guided by those who understand science from the inside. Consequently, this book provides both advice and encouragement for Christians entering or engaged in scientific careers because their presence in science is a vital component of the church's witness in the world.…

Paperback. Etat : Good. Many young Christians interested in the sciences have felt torn between two options: remaining faithful to Christ or studying science. Heated debates over the past century have created the impression that we have to choose between one or the other. The result has been a crisis of faith for many students. Josh Reeves and Steve Donaldson present a concise introduction to the study of science that explains why scientists in every age have found science congenial to their faith and how Christians in the sciences can bridge the gap between science and Christian belief and practice. If Christians are to have a beneficial dialogue with science, it will be guided by those who understand science from the inside. Consequently, this book provides both advice and encouragement for Christians entering or engaged in scientific careers because their presence in science is a vital component of the church's witness in the world.…

Etat : very_good. Book is in very good condition and may include minimal underlining highlighting. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service.

Etat : good. Book is in good condition and may include underlining highlighting and minimal wear. The book can also include "From the library of" labels. May not contain miscellaneous items toys, dvds, etc. . We offer 100% money back guarantee and 24 7 customer service.

hardcover. Etat : Fair.

Hardcover. Etat : Very Good. With dust jacket. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Paperback. Etat : Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Etat : Good. A sound copy with only light wear. Overall a solid copy at a great price.

Etat : good. Fast Free Shipping â" Good condition. It may show normal signs of use, such as light writing, highlighting, or library markings, but all pages are intact and the book is fully readable. A solid, complete copy that's ready to enjoy.

Etat : good. Fast & Free Shipping â" Good condition. It may show normal signs of use, such as light writing, highlighting, or library markings, but all pages are intact and the book is fully readable. A solid, complete copy that's ready to enjoy.

Etat : very_good. Fast Free Shipping â" Very Good condition book with a firm cover and clean pages. Shows normal use and some light wear or limited notes markings. A solid, nice copy to enjoy. Bishop, Nic (illustrateur).

Paperback. Etat : Very Good. 1. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Paperback. Etat : Good. Addressing fundamental questions about life, this unique volume examines the way in which distinguished scientists of different faiths explore the connections between science, ethics, spirituality and the divine.

Hardback. Etat : Very Good. For more than half a century, medical advances have been driven by investigators launching experiments inside labs. Science is often conducted in isolation and geared toward the long view. This is the story of a group of people who tried to force the lab doors open: parents whose children had been diagnosed with a rare and fatal genetic condition known as Niemann-Pick disease type C. The disease prevents cells from processing cholesterol, which leads to the progressive loss of the brain's and the body's ability to function. Recognizing that there would never be a treatment in time to save their children if things stayed the same, the parents set up a collaboration with researchers and doctors in search of a cure. Reconciling different views of science took work. The parents, doctors, and researchers didn't always agree - among themselves or with each other. But together they endeavored to accelerate the development of new drugs. The parents became citizen scientists, identifying promising new treatments and helping devise experiments. They recorded data about the children and co-authored scientific papers sharing findings. They engaged directly with the FDA at each step of the drug approval process. Along the way, they advanced the radical idea that science must belong to us all. Amy Dockser Marcus shows what happens when a community joins forces with doctors and researchers to try to save children's lives. Their extraordinary social experiment reveals new pathways for treating disease and conducting research. Science may be forever changed. …

Hardback. Etat : Fair. For more than half a century, medical advances have been driven by investigators launching experiments inside labs. Science is often conducted in isolation and geared toward the long view. This is the story of a group of people who tried to force the lab doors open: parents whose children had been diagnosed with a rare and fatal genetic condition known as Niemann-Pick disease type C. The disease prevents cells from processing cholesterol, which leads to the progressive loss of the brain's and the body's ability to function. Recognizing that there would never be a treatment in time to save their children if things stayed the same, the parents set up a collaboration with researchers and doctors in search of a cure. Reconciling different views of science took work. The parents, doctors, and researchers didn't always agree - among themselves or with each other. But together they endeavored to accelerate the development of new drugs. The parents became citizen scientists, identifying promising new treatments and helping devise experiments. They recorded data about the children and co-authored scientific papers sharing findings. They engaged directly with the FDA at each step of the drug approval process. Along the way, they advanced the radical idea that science must belong to us all. Amy Dockser Marcus shows what happens when a community joins forces with doctors and researchers to try to save children's lives. Their extraordinary social experiment reveals new pathways for treating disease and conducting research. Science may be forever changed.…

Hardback. Etat : Good. The fascinating story of the hidden world of bird-breeding, of contentious ideas in 1920s Germany, and of two amateur scientists who unwittingly managed to be decades ahead of their time. Long before Dolly the Sheep or bioengineered corn, there was the Red Canary-the first organism to be manipulated by genetic technology, back in the 1920s. The effort to produce a red canary invoked all of the deep issues that troubled genetic engineering decades later: the nature of genes and how they work, the specter of eugenics, and the relative roles of nature and nurture in determining what an organism is. Behavioral ecologist Tim Birkhead describes how a sweet-voiced green bird discovered by Spanish explorers in the 1300s became a craze in Renaissance Europe, how breeders gradually turned its green plumage to yellow, and how a pair of German scientists used the first bit of gene technology in the 1920s to produce an almost-red canary. But the true red canary would not come until the 1960s, when British scientists successfully bred one, and genes alone would not be sufficient to create one. A Brand New Bird is a compelling tale of a fascinating episode in the history of genetics.…

paperback. Etat : Good.

Mass Market Paperback. Etat : Fair. Reissue. The item might be beaten up but readable. May contain markings or highlighting, as well as stains, bent corners, or any other major defect, but the text is not obscured in any way.